RxDoctor Payments Data

Johnathan Goree, MD

Anesthesiology · Little Rock, ARNPI 1760625628

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 58.1% of the total. Among anesthesiology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$512,686in general payments, 2019–2025

Across 735 payments — averaging $697.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$298K
  • Abbott$162K
  • Stratus Medical, LLC$49K
  • MML US, Inc.$2K
  • Relievant Medsystems, Inc.$386
  • Nevro Corp.$361
  • plus $2K from 11 others
$404,805in research payments, 2019–2025

Across 57 payments — averaging $7101.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • SPR Therapeutics, Inc$256K
  • MML US, Inc.$148K
  • Saluda Medical Americas, Inc.$374
  • Abbott$92

What the payments were for

  • Consulting fees$289,86957%
  • Speaking & faculty fees$121,12524%
  • Travel & lodging$55,07111%
  • Food & beverage$27,4525%
  • Education$19,1694%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$512,686 in reported general payments places this provider in the 95th percentile of 300 anesthesiology providers in Arkansas.

See all anesthesiology providers in Arkansas

Medicare billing

Part B allowed, 2024
$81,817
Medicare patients
239
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin31$3,569
Fentanyl25$1,968
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$1,570
Gabapentin107$1,314
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$1,003
Methadone Hcl42$852
Baclofen28$420
Tramadol Hcl61$385
Duloxetine Hcl17$325
Tizanidine Hcl33$300
Celecoxib12$268
Meloxicam12$48
Methocarbamol11$48

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →